Valuation & Market

New data reveals a 'Women CEO Effect'—companies led by women don't just break ceilings, they build entirely new pipelines for female leadership.

Nuwellis bets on educating hundreds of physicians on its Aquadex system, a high-stakes strategy to combat fluid overload and secure its place in medicine.

BioCardia bets its future on Japan's fast-track approval for its heart therapy, a strategic pivot that could unlock global markets or break the bank.

Alight's 1-for-20 reverse split aims to save its NYSE listing. Is this a savvy strategic reset or a temporary fix for a stock facing deeper challenges?

Eason Technology leadership's big share purchase signals confidence. But with declining revenue and a "going concern" warning, is this a bet on a real turnaround?

Shokz's partnership with the Western States 100 isn't just a sponsorship; it's a masterclass in niche marketing. We deconstruct why a market-dominant brand is betting on 369 runners.

A court ruling clears the way for Curium's targeted cancer drug, promising new hope for patients and shaking up the multi-billion-dollar radiopharmaceutical market.

AudioEye appoints Matthew Domeyer as CFO, a strategic move to manage 41 quarters of growth and capitalize on regulatory tailwinds in the booming accessibility market.

Memo Therapeutics' Potravitug shows promise in a Phase II trial, offering the first real weapon against a common virus that threatens kidney transplants.

As OMS Energy prepares its FY2026 results, its performance offers a unique window into the future of oil & gas in the pivotal Asia-MENA corridor.

Nephros is moving from a product company to a service-based model. We unpack the strategy, financial risks, and why this pivot could redefine its market.

With a fresh $50M, Enhanced Group is selling a future of medically-guided peak performance. But can its controversial Games and peptide platform survive regulatory scrutiny?

As Retevis offers military-tested two-way radios on Prime Day, businesses are discovering that true reliability doesn't come from a smartphone.

Cross Timbers Royalty Trust's June distribution reveals a complex narrative of divergent commodity prices, falling volumes, and persistent operational costs.

As WestJet and the Blue Jays prepare a 'big-league reveal,' we analyze the strategic infrastructure of a partnership shaping fan loyalty and air travel.

As regulators tighten their grip on PFAS, Claros Technologies adds a seasoned growth expert to its board, aiming to replicate AI-sector scaling success.

Facing fee pressures and complexity, asset managers are shifting from product hype to 'operational alpha'—a quiet but radical focus on efficiency.

A landmark securities fraud lawsuit against Microsoft over its AI Copilot reveals a critical lesson: the gap between AI promises and reality has consequences.

The grocery giant leans on booming eCommerce and marketing profits to offset cost pressures, reaffirming its yearly outlook in a show of strategic confidence.

Zurich's Linvo AG is betting its future on AI, creating 'AI Advisor' roles to redefine wealth management. Is this the dawn of a new era for Swiss finance?